ロード中...
Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial
BACKGROUND: Psoriasis is an immune-mediated chronic inflammatory skin disorder for which several targeted biologic therapies became available in the last 10 years. Data from patients with rheumatoid arthritis revealed that dose tapering combined with tight control of disease activity is successful....
保存先:
| 出版年: | BMC Dermatol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5422943/ https://ncbi.nlm.nih.gov/pubmed/28482858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12895-017-0057-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|